# Pericapsular Nerve Group (PENG) Block for Congenital Hip Dislocation Surgery

> **NCT04212039** · NA · COMPLETED · sponsor: **Ataturk University** · enrollment: 48 (actual)

## Conditions studied

- Congenital Hip Dysplasia

## Interventions

- **DRUG:** Saline Solution
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT04212039
- **Lead sponsor:** Ataturk University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04212039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04212039, "Pericapsular Nerve Group (PENG) Block for Congenital Hip Dislocation Surgery". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04212039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*